(MedPage Today) — CHICAGO — Upfront surgery for advanced ovarian cancer failed to improve overall survival (OS) versus interval debulking but did improve progression-free survival (PFS) for the first time in a phase III trial.
Patients with…
Source link : https://www.medpagetoday.com/meetingcoverage/asco/115920
Author :
Publish date : 2025-06-05 16:07:00
Copyright for syndicated content belongs to the linked Source.
